LakeShore Biopharma Co (LakeShore Biopharma Co) ROE % Adjusted to Book Value : -53.61% (As of Sep. 2023)

View and export this data going back to 2023. Start your Free Trial

What is LakeShore Biopharma Co ROE % Adjusted to Book Value?

LakeShore Biopharma Co's ROE % for the quarter that ended in Sep. 2023 was -52.54%. LakeShore Biopharma Co's PB Ratio for the quarter that ended in Sep. 2023 was 0.98. LakeShore Biopharma Co's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2023 was -53.61%.

LakeShore Biopharma Co ROE % Adjusted to Book Value Historical Data

The historical data trend for LakeShore Biopharma Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LakeShore Biopharma Co ROE % Adjusted to Book Value Chart

LakeShore Biopharma Co Annual Data

Trend

Mar21

Mar22

Mar23

ROE % Adjusted to Book Value

LakeShore Biopharma Co Semi-Annual Data
	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial			-	-	-	-	-53.61

Competitive Comparison of LakeShore Biopharma Co's ROE % Adjusted to Book Value

For the Biotechnology subindustry, LakeShore Biopharma Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

LakeShore Biopharma Co's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LakeShore Biopharma Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where LakeShore Biopharma Co's ROE % Adjusted to Book Value falls into.

LakeShore Biopharma Co ROE % Adjusted to Book Value Calculation

LakeShore Biopharma Co's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	1.41
	=	0.00%

LakeShore Biopharma Co's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-52.54%	/	0.98
	=	-53.61%

LakeShore Biopharma Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of LakeShore Biopharma Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

LakeShore Biopharma Co (LakeShore Biopharma Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LakeShore Biopharma Co Ltd (NAS:LSB) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

H6Z:Germany

Address

38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629

Website

https://www.yishengbio.com

YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminium-free lyophilized rabies vaccine that was launched in China. It has one operating segment, which is the development, production, marketing and sale of biopharmaceutical products.